Industrials

Everus Construction Group, Inc. (ECG)

$5.8B
Market Cap
28.9
P/E Ratio
Beta
Dividend Yield
Piotroski 5/9Altman Z 6.7 SafeBeneish M -2.12 Flag (> −2.22)ROIC−WACC +11.5%

Quantitative Summary

Deterministic

At 28.9x earnings — a 36% discount to the sector average of 44.7x — ECG is in the lower valuation range. Financial health is average: Piotroski 5/9, Altman Z 6.7. Beneish M-Score of -2.12 exceeds the -2.22 academic threshold — earnings quality may warrant further review.

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Algorithmic Teardown

AI-Generated

The fundamental economics of Everus Construction Group reveal a capital allocation profile with significant value creation potential, evidenced by an ROIC-WACC spread of +11.5%, indicating the company generates returns well above its cost of capital. This efficiency is underpinned by strong operational leverage and growth momentum; while net margins remain modest at 5.4% against gross margins of 12.1%, revenue expansion has accelerated to 31.5% year-over-year, suggesting a high-turnover DuPont ROE driver rather than margin compression or excessive leverage. Financial integrity appears robust based on the Altman Z-Score of 6.7 and Beneish M-Score of -2.12, which collectively signal low bankruptcy risk and minimal earnings manipulation concerns. However, the Piotroski F-Score of 5/9 indicates moderate financial strength with room for improvement in specific quality metrics compared to top-tier peers.

Valuation analysis presents a divergence between market pricing and intrinsic value estimates. The current P/E ratio of 28.9x trades at a substantial discount relative to the sector average of 45.7x, yet it remains elevated when contrasted against the DCF-derived fair value of $15 per share. This discrepancy suggests that while the stock offers some protection from sector-wide multiples, the market may still be pricing in aggressive growth assumptions or liquidity premiums not fully captured by the discounted cash flow model's implied trajectory. Investors must weigh whether the 31.5% revenue surge justifies a multiple closer to the historical mean or if the current valuation reflects an expectation of sustained high-growth execution that could compress future margins.

No specific risk factor deltas, insider activity data, or Fama-French alpha metrics were provided for this analysis; consequently, the risk-reward profile relies entirely on the interplay between the company's strong cash flow generation and its valuation gap relative to intrinsic worth. The combination of a wide ROIC spread and low manipulation scores supports a view of operational quality, but the premium over fair value implies that downside protection is limited until growth rates normalize or multiple compression occurs.

Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.

DCF Sandbox

Interactive

Sensitivity Matrix

TG ↓ / WACC →8.7%10.7%12.7%
2%$18$13$11
3%$20$15$12
4%$24$17$13

Center = base case. Green = >10% upside, Red = >10% downside vs .

Pre-computed DCF: WACC=10.7%, terminal growth 3%. Fair value $15 (+0.0%). Not investment advice.

Valuation Context

28.9x
ECG P/E
44.7x
Sector Avg
-36%
vs Sector

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Quant Health Deep Dive

5/9
Piotroski F-Score
Average — mixed operational signals
6.7
Altman Z-Score
Safe Zone — above 3.0 threshold per academic model. Thresholds: >3 safe, 1.8–3 grey, <1.8 distress.
-2.12
Beneish M-Score
Above threshold — earnings quality may warrant further review per Beneish model. Threshold: <-2.22 = below threshold.

Profitability & Value Creation

12.1%
Gross Margin
5.4%
Net Margin
22.2%
ROIC
10.7%
WACC
ROIC − WACC Spread: +11.5%— Positive value creation spread.
+31.5%
Revenue Growth (YoY)
+40.7%
Earnings Growth (YoY)
90.0M
Free Cash Flow

Balance Sheet Health

1.74x
Debt / Equity
1.76x
Current Ratio
13.0x
Interest Coverage
0.3x
Net Debt / EBITDA
1.52%
FCF Yield
308.1M
EBITDA

Earnings Surprise History

Q4
✓ Beat
Est: $0.43
Act: $0.72
+67.4%
Q3
✓ Beat
Est: $0.59
Act: $1.03
+74.6%
Q2
✓ Beat
Est: $0.62
Act: $1.11
+80.0%
Q1
✓ Beat
Est: $0.77
Act: $1.08
+40.6%

EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fundamentals

25.0
Forward P/E
PEG Ratio
9.23
Price/Book
686800
Avg Volume
$137.64
52W High
$31.38
52W Low
52W Range Position

Passive Flow Attribution

ETF Draft Effect
$515M
Tracked Passive Exposure
8
ETFs Holding ECG
0.13%
Avg Weight in ETFs
$402B
Total ETF AUM

When investors buy or sell ETFs like SLYG or IJT, the fund manager is mechanically forced to buy or sell ECG shares regardless of Everus Construction Group, Inc.'s individual fundamentals. We estimate $515M of passive capital is structurally linked to ECG through 8 tracked ETFs. Passive flows have a limited but growing influence on ECG's daily trading dynamics.

Passive exposure = Σ (ETF AUM × stock weight in ETF) across 8 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.

ETF Contagion Visualizer

Simulate a price drop in Everus Construction Group, Inc. to visualize passive redemption contagion across ETFs and collateral stocks.

ECG Shock
-0%
Est. Passive Redemption
$0
Systemic Risk
STABLE
ECGEpicenterVBETFVXFETFVBRETFSANMMed RiskVIAVHigh RiskSMTCUnknownFORMLow RiskVSATHigh Risk
ECG Price Drop (%)0

If Everus Construction Group, Inc. (ECG) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies SANMINA CORP (SANM) as the most exposed collateral stock, sharing 2 ETFs with ECG. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.

Contagion model based on shared ETF exposure and constituent weights across 12 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.

ECG Ownership Dynamics

Ticker
ECG

Float lock-up computed from 11 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).

ECG Capital Efficiency

How efficiently does Everus Construction Group, Inc. convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.

Free Cash Flow
$90M
EBITDA
$308M
FCF Conversion
29%
Reinvestment Rate
71%
29% of EBITDA → Free Cash
0% (cash burn)25% (low)50% (efficient)100% (pure cash)
ROIC
22.2%
ROIC − WACC Spread
11.5%

Everus Construction Group, Inc. converts 29% of its EBITDA into free cash flow, a moderate conversion rate — significant EBITDA is consumed by capital expenditures, working capital changes, or interest payments. The 71% reinvestment rate signals aggressive capacity expansion. The positive ROIC-WACC spread of 11.5% confirms that reinvested capital creates shareholder value.

Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.

Fails-to-Deliver (FTD) History

SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.

DateFailed SharesClose PriceNotional Value
2026-04-243,025$136.33$412,398.25
2026-04-20110$128.81$14,169.1
2026-04-171$126.52$126.52
2026-03-2619,337$123.29$2.4M
2026-02-249,089$106.08$964,161.12
2026-02-231,718$108.16$185,818.88
2026-02-2016,801$104.53$1.8M
2026-02-0593$85.69$7,969.17
2026-01-30375$92.03$34,511.25
2025-12-0819,048$91.75$1.7M
2025-11-261,595$87.45$139,482.75
2025-11-2418,460$82.48$1.5M
2025-11-216,137$80.42$493,537.54
2025-11-142,800$91.58$256,424
2025-11-054,153$86.63$359,774.39

Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.

Compare ECG to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: N/A.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.